Free Trial
NASDAQ:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.32 +0.04 (+14.55%)
(As of 11/22/2024 ET)

About Biotricity Stock (NASDAQ:BTCY)

Key Stats

Today's Range
$0.27
$0.33
50-Day Range
$0.20
$0.57
52-Week Range
$0.19
$1.67
Volume
68,044 shs
Average Volume
78,078 shs
Market Capitalization
$7.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

Biotricity's (BTCY) "Neutral" Rating Reiterated at HC Wainwright
H.C. Wainwright Reaffirms Their Hold Rating on Biotricity (BTCY)
Let’s be blunt
Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!
Biotricity (NASDAQ:BTCY) Trading Up 12.6% - Should You Buy?
Biotricity, Inc. (BTCY) Q2 2025 Earnings Call Transcript
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $1.15 at the start of the year. Since then, BTCY stock has decreased by 72.6% and is now trading at $0.3150.
View the best growth stocks for 2024 here
.

Biotricity, Inc. (NASDAQ:BTCY) announced its quarterly earnings data on Thursday, June, 27th. The company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.36) by $0.11. The firm earned $3.18 million during the quarter, compared to analyst estimates of $3.20 million.

Biotricity (BTCY) raised $15 million in an IPO on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include TransDigm Group (TDG), Taiwan Semiconductor Manufacturing (TSM), Wix.com (WIX), Datadog (DDOG), Quanta Services (PWR), PayPal (PYPL) and Royal Caribbean Cruises (RCL).

Company Calendar

Last Earnings
6/27/2024
Today
11/23/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BTCY
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Net Income
$-14,090,000.00
Pretax Margin
-97.04%

Debt

Sales & Book Value

Annual Sales
$12.06 million
Book Value
($1.38) per share

Miscellaneous

Free Float
20,331,000
Market Cap
$7.73 million
Optionable
Optionable
Beta
1.22
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:BTCY) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners